Explore ViiV Healthcare
Report adverse event
If you are a patient and have experienced an unexpected event when taking one of our medications please speak to your healthcare professional as soon as possible. To lodge a report contact:
Phone: 1800 499 226
DOVATO (dolutegravir/lamivudine) is listed on the Australian Register of Therapeutic Goods (ARTG).
DOVATO is indicated for the treatment of HIV-1 infection in antiretroviral treatment-naïve adults and adolescents (from 12 years of age weighing at least 40 kg) who have no known or suspected resistance to either antiretroviral component.
This product is not PBS listed.